Cardiac Concepts Inc., a med-tech firm that’s remained largely quiet since raising $21 million in venture capital in 2008, has launched a clinical trial in Europe.
The Minnetonka-based firm has enrolled its first patient in the study, which will examine how its implantable device can help heart failure patients who suffer from sleep apnea. The company’s product, the RespiCardia System, is designed to treat central sleep apnea, where breathing is disrupted when muscles in the chest don’t work properly. The company will test its device on 40 patients.
Central sleep apnea is different from obstructive sleep apnea, a condition that causes throat muscles to contract. Twin Cities firms, including Apnex Medical Inc., are developing implantable devices to treat that condition.
[Press Release]-/Newport Beach, CA (SleepApneaDisorder)/ July 30, 2010/-Glidewell Dental Lab (www.glidewelldental.com), provider of dental appliances for the treatment of snoring and sleep apnea, has successfully launched its newest product to dentists and patients: the aveoTSD (www.getaveo.com). A simple, inexpensive anti-snoring device, the aveoTSD is an effective form of treatment for problem snoring. Available to patients through dentist, physician or medical specialist prescription, this easy-to-use, noninvasive anti-snoring aid improves health and quality of life.
An estimated 80 million people in the U.S. are affected by a chronic sleep disorder. Snoring is the most common and is caused by a narrowing of the upper airway during sleep. Read the rest of this entry
[Press Release]/ July 29, 2010 – ROSEVILLE, CA,/ – Roseville dentist Preddis L. Sullivan DDS, a member of the American Academy of Dental Sleep Medicine, knows how effective an oral appliance can be in the treatment of a common sleep disorder known as obstructive sleep apnea (OSA). Many of his patients have found much needed relief through this simple treatment option.
New professional guidelines have provided further support for what both Dr. Sullivan and his patients already know: oral appliances, which are similar in appearance to an orthodontic retainer or a sports mouthguard, are an excellent treatment option for patients with mild to moderate sleep apnea. Read the rest of this entry
A new dental mouthpiece has been developed to help patients with sleep apnea.
The Full Breath Solution can be used to treat people with mild or moderate sleep apnea and is also beneficial for those who snore.
The mouthpiece device was invented by Dr Bryan Keropian.
Dr Keropian says,”the mouthpiece would provide an alternative to the continuous positive airway pressure machine, which some patients find uncomfortable and invasive”. Read the rest of this entry
Ensure your sleep apnea equipment is working efficiently and effectively with one-on-one service from respiratory specialists at a free CPAP/BiPAP Clinic from 8 a.m. to 4 p.m. Tuesday at Elkhart General Home Medical Equipment, 225 E. Jackson Blvd.
Appointments take only 20 minutes and include: pressure checks, mask and supply evaluations, filter changes and new equipment displays.
GlobalData’s medical equipment report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2016″ provides key market data on the Spain anesthesia and respiratory devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems. Read the rest of this entry
Landon Medical, the leading manufacturer of Pulse Oximeters revolutionizes the oximeter industry with the first affordable, FDA-approved Landon Medical LM-800 Fingertip Pulse Oximeter priced at $39.
The LM-800 Fingertip Pulse Oximeter measures SpO2 (percentage of oxygen saturation in the blood) and pulse rate with accuracy and ease. Specifically manufactured to be lightweight and portable the LM-800 model provides fast and accurate readings of blood oxygen saturation and pulse rate. Small and compact, it provides complete oximetry solutions while still able to fit in your pocket.
“It is without a doubt that affordability of a pulse oximeter is one of the largest barriers to patients purchasing this incredible medical device,” said Dr. Shiv Khanna of the Lavale Clinic based in Cumberland, MD. “However, an oximeter priced at $39 is truly a step in the right direction as far as allowing those who couldn’t typically afford a pulse oximeter access to this essential medical device.”
The LM-800 Pulse Oximeter is a widely-used medical device all healthcare facilities, including hospitals, nursing homes, outpatient surgery centers, physician offices, dentist offices, emergency and ambulatory situations, sport athletes, as well for home diagnostics for monitoring such illnesses as sleep apnea,COPD, cardiac problems, respiratory issues, asthma, and many more.
Cinterion and one of its partners – Royal Philips Electronics – recently jointly won the ‘Best Embedded End-to-End Service Award’, part of the GSMA’s embedded mobile competition, for its Respironics System One sleep therapy solution. The M2M solution integrates one of Cinterion’s award-winning Evolution platform modules and marries mobility and reliable two-way wireless communications with advancements in sleep apnea therapy to help millions of patients and their healthcare providers who must meet rigorous new reporting standards. Read the rest of this entry
The new medical equipment report, ‘Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016′ provides key market data on the Korea anesthesia and respiratory devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems. Read the rest of this entry
There is a new home based device that can be potentially used for monitoring health issues – such as sleep apnea at home.
With this new device a patient’s vital signs are typically taken once every four to eight hours. The cuff works overtime, measuring a patient’s blood oxygen levels, heart rhythm and rate, respiration and blood pressure, every 60 seconds. The data is sent wirelessly to a central computer. If something goes wrong, an alert sounds. Read the rest of this entry
GlobalData’s medical equipment report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2016″ provides key market data on the Spain anesthesia and respiratory devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – anesthesia disposables, anesthesia machines, respiratory devices, respiratory disposables, respiratory measurement devices, and sleep apnea diagnostic systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
[Press Release]- Graymark Healthcare Inc. the nation’s second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea today announced that it sold a record number of CPAP machines in Q2 providing relief to over 750 patients. In addition they served over 1275 patients through their CPAP re-supply service.
Graymark Healthcare has been pioneering better techniques for ensuring that patients diagnosed with Obstructive Sleep Apnea (OSA) are quickly and effectively treated in an effort to optimize clinical outcomes. Graymark has driven improved patient compliance with CPAP care and overall disease management by integrating the diagnostic and treatment processes.
“In Q4 of 2009 we at Graymark Healthcare announced the launch of our comprehensive care model aimed at improving the conversion rate of patients diagnosed with obstructive sleep apnea to successful care with a CPAP device. We have seen consistent month over month growth in our therapy services this year and had record patient therapy volumes in Q2. We expect continued momentum through Q3 and associated strong performance,” said Stanton Nelson, Chairman and CEO of Graymark Healthcare. “We believe that our revolutionary comprehensive care model better serves our patients and is more cost effective than the fragmented care provided in other settings. Additionally, our re-supply program ensures that our patients are contacted no less than quarterly and that we can continue to work with them to improve their CPAP experience,” added Nelson. Read the rest of this entry
Cardiac Concepts Inc., a med-tech firm that’s remained largely quiet since raising $21 million in venture capital in 2008, has launched a clinical trial in Europe.
